|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-1-22
|
|
pubmed:abstractText |
The tumour suppressor gene p16INK4a is a cyclin-dependent kinase inhibitor, for which inactivation attributable to promoter hypermethylation or homozygous deletion has been described in malignancies. Little is known about p16INK4a protein levels in renal cell carcinoma (RCC) and its association with clinicopathologic parameters or disease progression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
732-7; discussion 738
|
|
pubmed:meshHeading |
pubmed-meshheading:16949731-Carcinoma, Renal Cell,
pubmed-meshheading:16949731-Cyclin-Dependent Kinase Inhibitor p16,
pubmed-meshheading:16949731-Female,
pubmed-meshheading:16949731-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16949731-Humans,
pubmed-meshheading:16949731-Kidney Neoplasms,
pubmed-meshheading:16949731-Male,
pubmed-meshheading:16949731-Middle Aged,
pubmed-meshheading:16949731-Prognosis,
pubmed-meshheading:16949731-Survival Rate
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
p16INK4a expression and clinicopathologic parameters in renal cell carcinoma.
|
|
pubmed:affiliation |
Department of Urology, Medizinische Hochschule Hannover, Hannover, Germany.
|
|
pubmed:publicationType |
Journal Article
|
